The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...

The European Medicines Agency (EMA) has already announced its own fast-track rolling reviews of AZ's vaccine and a rival from Pfizer/BioNTech, although it has not given a timeline for a regulatory ...

Robert Redfield says he's "proud" of work on President Trump's initiative but believes COVID vaccines should be "critically ...

In early European trade, Bavarian Nordic shares fell as much as 19%, while Valneva shares dropped as much as 10%. GSK and ...

Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global ...

Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was ...

From the beginning of December, free Covid vaccines will be available at GPs and children will be able to get the vaccine at ...

To potentially include adolescents and antibody persistence up to two years Saint Herblain (France), November 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass vaccination. Britain's medicines regulator, the MHRA, says the jab, which ...